Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire Atraverse Medical, Inc., a privately-held medical device company pioneering next-generation left-heart access and radiofrequency (RF) technology. Achieving safe and precise access to the left atrium remains one of the most critical steps in atrial fibrillation ablation. Atraverse Medical’s HOTWIRE™ Transseptal Access System, already used in nearly 3,000 clinical procedures, is an FDA-cleared RF guidewire and generator system that is designed for greater confidence and control when accessing the left atrium.
Read the full article: Johnson & Johnson Enters Agreement to Acquire Atraverse Medical //
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-enters-agreement-to-acquire-atraverse-medical